
SNMMI 2026 Annual Meeting
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to SNMMI 2026 Annual Meeting — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
SNMMI Annual Meeting 2026
Event type: Nuclear medicine, molecular imaging, radiopharmaceuticals, PET/SPECT imaging, clinical research, diagnostics, healthcare technology, and medical education
Audience profile: Physicians, radiologists, nuclear medicine specialists, hospital buyers, imaging center leaders, researchers, pharmacists, radiation safety professionals, biotech companies, device manufacturers, distributors, and healthcare solution providers
Estimated attendance: Typically a strong professional healthcare event with thousands of attendees, including clinical decision-makers, researchers, and vendor partners from across the United States and international markets
1️⃣ Who attends: Buyers / attendees
This event attracts a highly specialized healthcare and life sciences audience. The strongest buyer segments are not general consumers, but clinical and technical professionals who influence purchasing, adoption, protocol decisions, procurement, and research partnerships.
Primary attendee groups include:
- Nuclear medicine physicians
- Radiologists and imaging specialists
- Hospital procurement and supply chain teams
- Imaging center directors and administrators
- Radiopharmacy leaders and radiochemists
- Medical physicists and radiation safety professionals
- Clinical researchers and trial teams
- Biotech, pharmaceutical, and radiopharmaceutical company representatives
- Medical device and imaging equipment vendors
- Healthcare IT, PACS, and workflow solution providers
- Academic medical centers and university research groups
- Distributors and channel partners serving healthcare systems
For attendee-list monetization, the best buyers are usually those with budget authority or strong influence over imaging, diagnostics, radiopharmaceuticals, workflow optimization, safety, and clinical operations.
2️⃣ Where the show is happening + attendee geographic origin
SNMMI Annual Meeting 2026 is a major professional conference for the nuclear medicine and molecular imaging community. The exact venue details should be confirmed from the event’s official listing, but the event is generally a U.S.-based national conference with strong international participation.
Geographic origin of attendees:
- Local: Attendees from the host city and surrounding region
- National: Strong attendance from hospitals, imaging centers, universities, and diagnostic providers across the United States
- Global: International researchers, clinicians, radiopharmaceutical firms, and imaging technology companies also participate
Best geographic targeting should prioritize U.S. healthcare buyers first, then add international pharma, biotech, and diagnostics companies with global operations.
3️⃣ Audience reach
Reach type: National with global influence
This is not a local event in practical buyer terms. It is a specialized healthcare meeting with national importance and international relevance. The attendee base includes buyers and influencers from leading hospitals, research centers, academic institutions, and commercial healthcare companies.
For list sales, this means the audience is highly targeted and commercially valuable, especially for companies selling imaging systems, contrast agents, radiopharmaceuticals, software, lab technology, clinical tools, and healthcare services.
4️⃣ Sample buyer company names + websites
Below are sample buyer-style companies that fit well for this conference. These are the kinds of accounts you can prioritize when building a targeted attendee or buyer list. I have included a mix of hospitals, life sciences, diagnostics, imaging, and healthcare technology companies.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | GE HealthCare | gehealthcare.com | Product Marketing Manager, Molecular Imaging / Clinical Affairs Manager | Direct fit for imaging systems, diagnostics, hospital relationships, and nuclear medicine workflows. |
| 2 | Siemens Healthineers | siemens-healthineers.com | Business Development Manager / Clinical Marketing Manager | Strong buyer for imaging technology, hospital solution sales, and advanced diagnostics. |
| 3 | Philips | philips.com | Imaging Solutions Manager / Healthcare Partnerships Director | Relevant for hospital imaging, workflow software, and enterprise healthcare relationships. |
| 4 | Bracco Imaging | bracco.com | Medical Affairs Manager / Product Manager, Diagnostics | Very strong fit for contrast media, imaging support, and clinical education audiences. |
| 5 | Curie Therapeutics | curietherapeutics.com | Clinical Development Director / Radiopharmaceutical Strategy Lead | Radiopharmaceutical and theranostics company with direct relevance to this audience. |
| 6 | Lantheus | lantheus.com | Brand Manager / Medical Science Liaison | Strong molecular imaging and radiopharmaceutical alignment. |
| 7 | Blue Earth Diagnostics | blueearthdiagnostics.com | Medical Affairs Director / Market Access Manager | Relevant for imaging agents, clinical education, and hospital adoption. |
| 8 | Cardinal Health | cardinalhealth.com | Radiopharmacy Operations Manager / Healthcare Supply Chain Director | Excellent fit for healthcare distribution, radiopharmacy, and hospital supply needs. |
| 9 | Siemens Molecular Imaging | siemens.com | Regional Sales Manager / Clinical Applications Specialist | Key account type for imaging centers, hospitals, and academic institutions. |
| 10 | United Imaging Healthcare | united-imaging.com | Sales Director / Channel Partner Manager | Strong fit for advanced imaging equipment and hospital expansion. |
| 11 | Medtronic | medtronic.com | Clinical Marketing Manager / Health System Account Manager | Relevant if the buyer needs hospital technology, clinical workflow, or procedural solutions. |
| 12 | Canon Medical Systems | us.medical.canon | Modality Manager / Imaging Sales Director | Highly relevant for imaging centers, radiology departments, and hospital procurement. |
| 13 | Bayer | bayer.com | Diagnostics Marketing Manager / Medical Affairs Lead | Good fit for healthcare diagnostics, imaging support, and clinical adoption. |
| 14 | Pfizer | pfizer.com | Medical Affairs Director / Oncology Partnerships Manager | Useful if targeting pharma teams connected to imaging, oncology, and clinical research. |
| 15 | Bristol Myers Squibb | bms.com | Clinical Development Manager / Medical Science Liaison | Strong fit for research-driven healthcare engagement and clinical partnerships. |
| 16 | Thermo Fisher Scientific | thermofisher.com | Product Manager, Clinical Diagnostics / Business Development Manager | Relevant for lab diagnostics, life sciences tools, and research workflow solutions. |
| 17 | Danaher | danaher.com | Commercial Director / Healthcare Portfolio Manager | Strong healthcare, diagnostics, and life sciences ecosystem buyer. |
| 18 | Hologic | hologic.com | Marketing Manager, Diagnostics / Strategic Account Manager | Good fit for diagnostic tools, hospital relationships, and clinical decision-makers. |
Top 5 best samples to send first: GE HealthCare, Siemens Healthineers, Bracco Imaging, Cardinal Health, and Curie Therapeutics.
5️⃣ Job profiles, industries & event type
Best job profiles to target:
- Director of Nuclear Medicine
- Chief Radiology Officer
- Medical Director, Imaging
- Clinical Affairs Manager
- Medical Science Liaison
- Product Manager, Diagnostics
- Product Marketing Manager, Imaging
- Radiopharmacy Manager
- Hospital Procurement Manager
- Healthcare Purchasing Director
- Imaging Center Administrator
- Research Director
- Health System Account Manager
- Business Development Director
- Clinical Applications Specialist
- Market Access Manager
- Radiation Safety Officer
- Operations Director, Diagnostic Services
Best industry filters to use:
- Hospital & Health Care
- Medical Devices
- Pharmaceuticals
- Biotechnology
- Research
- Health, Wellness & Fitness
- Biotech and Diagnostics related company keywords
- Medical Practice
- Information Technology & Services for healthcare software vendors
- Medical Devices for imaging and equipment providers
- Pharmaceuticals for radiopharmaceutical and therapy companies
Event type: A scientific and commercial healthcare conference with a strong mix of education, product showcase, clinical exchange, and business development.
6️⃣ Estimated attendance / expected footfall
The event should be treated as a high-value specialized conference rather than a broad public exhibition. While exact attendance varies year to year, this type of meeting usually attracts several thousand qualified attendees, with strong concentration among clinicians, researchers, and healthcare vendors.
Estimated footfall profile:
- Core professional attendees: several thousand
- Highly qualified clinical and research buyers: a smaller but very valuable segment
- Exhibitors and vendor staff: significant commercial presence
- Decision-makers: concentrated among hospitals, imaging networks, pharma, and medical technology firms
For list sales, this is a quality-over-quantity event. The attendee base is smaller than giant consumer conferences, but the buying value per contact is much higher.
7️⃣ Key focus areas & buyer engagement
Main focus areas likely include:
- Nuclear medicine imaging
- Molecular imaging
- Radiopharmaceutical innovation
- Theranostics
- PET and SPECT technology
- Clinical trials and translational research
- Oncology imaging
- Neurology and cardiac imaging applications
- Radiation safety and workflow optimization
- Healthcare data, AI, and imaging software
Buyer engagement opportunities:
- Clinical product demonstrations
- Research collaboration discussions
- Hospital procurement meetings
- Medical education sessions
- Theranostics and radiopharmacy presentations
- Brand awareness among specialists who influence future adoption
The strongest commercial angle is to position outreach around clinical influence, research partnerships, procurement, and technology adoption. This is especially effective if the client offers imaging systems, diagnostics, radiopharmaceuticals, software, workflow tools, lab equipment, or healthcare services.
8️⃣ Client-product fit note
Before finalizing the best buyer list, please share your client website. That is important because the ideal buyer profile changes depending on what the client is selling.
Examples:
- If the client sells imaging equipment, focus on hospital imaging directors, radiology leaders, and procurement teams.
- If the client sells radiopharmaceuticals, focus on medical affairs, clinical development, nuclear medicine physicians, and radiopharmacy leaders.
- If the client sells software or workflow tools, target imaging operations managers, healthcare IT, and department administrators.
- If the client sells diagnostic or lab products, prioritize clinical researchers, product managers, and lab operations buyers.
- If the client sells services, target business development, partnerships, and hospital decision-makers.
Once you share the client website, I can refine this into a much stronger buyer shortlist based on exact product-market fit.
9️⃣ Final recommendation
This is a strong event for highly targeted B2B attendee-list sales because the audience is specialized, professional, and commercially relevant. It is especially good for healthcare, diagnostics, medical imaging, biotech, and pharmaceutical outreach.
Best buyer segments to collect:
- Hospital and health system decision-makers
- Nuclear medicine and imaging leaders
- Radiopharmacy and radiopharmaceutical companies
- Clinical researchers and academic medical centers
- Medical device and diagnostics vendors
- Healthcare procurement and operations teams
- Product, marketing, and commercial leaders in imaging and diagnostics
Overall quality rating for B2B attendee-list sales: 9/10
Reason: highly targeted audience, strong buying influence, excellent industry fit, and strong value for companies selling into healthcare, diagnostics, imaging, and clinical research.
Next step: Please share your client website so I can review it and identify the best buyer companies, titles, and industry filters based on the exact product or service being sold.
Data sheet
| Event Name | SNMMI 2026 Annual Meeting |
| Event Date | May 30, 2026 – June 2, 2026 |
| Event Status | Completed |
| Venue | Los Angeles Convention Center |
| City | Los Angeles |
| State / Region | California |
| Country | United States |
| Organizer | Society of Nuclear Medicine and Molecular Imaging (SNMMI) |
| Official Event Website | snmmi.org |
| Event Type | Annual medical society meeting, scientific congress, healthcare exhibition, education and industry partnership event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology |
| Audience Reach | National with international specialist participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer in the information reviewed for this data sheet. Historical pattern suggests a large specialist medical meeting with thousands of attendees. |
| Attendance Data Reliability | Estimated / historical positioning; current-year attendee count not confirmed |
| Main Purpose of Event | To convene nuclear medicine, molecular imaging, radiopharmaceutical, hospital, research, and industry stakeholders for education, scientific exchange, product discovery, procurement influence, partnership development, and clinical adoption discussions. |
SNMMI 2026 Annual Meeting is the flagship annual gathering of the Society of Nuclear Medicine and Molecular Imaging, bringing together physicians, imaging specialists, radiopharmacy stakeholders, researchers, hospital leaders, and healthcare suppliers focused on nuclear medicine and molecular imaging. The event sits at the intersection of clinical practice, diagnostics, radiopharmaceutical innovation, imaging systems, software, safety, and scientific research.
From a commercial standpoint, this meeting matters because purchase decisions in this market are typically influenced by clinical leadership, department heads, supply chain teams, research institutions, pharmacy and radiopharmacy functions, and hospital administration rather than general consumers. It is therefore relevant for lead generation involving medical devices, radiopharmaceutical supply, imaging workflow software, hospital technology, research services, and specialized healthcare partnerships.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Nuclear medicine physicians | Hospitals, academic medical centers, specialty clinics | Strong clinical influence on modality choice, radiopharmaceutical usage, protocols, and vendor preference | Critical for product adoption, evaluations, pilot studies, and peer advocacy |
| Radiologists and imaging specialists | Integrated health systems, imaging groups, diagnostic centers | Influence equipment upgrades, software workflows, interoperability, and image quality requirements | High-value audience for imaging systems, PACS, AI, and workflow tools |
| Hospital procurement and supply chain teams | Health systems, hospitals, group purchasing structures | Commercial gatekeepers for contracts, vendor approvals, budgeting, and sourcing | Direct relevance for consumables, equipment, service contracts, and enterprise software |
| Imaging center directors and administrators | Outpatient imaging centers, hospital imaging departments | Operational and budget influence across staffing, throughput, systems, and vendor management | Good targets for efficiency, scheduling, workflow, maintenance, and service offerings |
| Radiopharmacy leaders and pharmacists | Hospital pharmacies, nuclear pharmacies, radiopharmaceutical providers | Influence sourcing, handling, safety, compliance, and supply continuity | Relevant for radiopharmaceutical supply, shielding, storage, logistics, and compliance solutions |
| Medical physicists and radiation safety professionals | Hospitals, universities, research institutions | Technical evaluators for dosimetry, safety systems, QA, and equipment validation | Important for technical credibility and specification alignment |
| Clinical researchers and trial teams | Academic centers, CRO-linked institutions, research hospitals | Shape adoption through evidence generation, study design, and investigator networks | Relevant for trial services, imaging analytics, biomarkers, and translational partnerships |
| Biotech, pharmaceutical, and radiopharmaceutical business units | Drug developers, radioligand companies, diagnostics firms | Partnership buyers, trial sponsors, channel builders, and commercialization stakeholders | High relevance for co-development, licensing, supply, and launch support |
| Healthcare IT and imaging informatics leaders | Hospitals, imaging networks, enterprise health systems | Evaluate PACS, RIS, interoperability, AI, cybersecurity, and data systems | Strong fit for software, integration, cloud, and analytics vendors |
| Distributors and channel partners | Medical distributors, regional technical resellers, specialty channel firms | May influence market access, local service capability, and account penetration | Useful for indirect sales expansion where specialized product support is needed |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Los Angeles | Local hospital systems, imaging groups, academic centers, and Southern California medical professionals | High local concentration of hospitals, research institutions, and health technology stakeholders | Strong local access for field sales meetings and regional account development |
| California | Health systems, university hospitals, biotech and life sciences organizations statewide | Very high | California is a major healthcare, medical technology, and life sciences market |
| Western United States | Attendees from Arizona, Nevada, Washington, Oregon, Utah, Colorado, and neighboring states | High regional specialist concentration | Convenient destination for western US hospital and academic buyers |
| National United States | Physicians, researchers, hospital buyers, vendors, and society members from across the US | Very high | The annual meeting format indicates broad national pull across the specialty |
| International specialist markets | Selective participation from global molecular imaging, radiopharma, and academic communities | Medium to high in specialist subsegments | International relevance is likely, but specific country breakdown was not confirmed in the information reviewed |
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | As the annual meeting of a major US specialty society, the event is best classified as national with strong participation from healthcare systems, academic medicine, and industry across the United States. |
| International | Secondary reach | The subject matter has global relevance in imaging and radiopharmaceuticals, though the current-edition country mix was not confirmed in the information reviewed. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| UCLA Health | Academic health system | Major Los Angeles-area health system with imaging, nuclear medicine, research, and hospital procurement functions | uclahealth.org | Director of Imaging, Nuclear Medicine Medical Director, Supply Chain Director, Pharmacy Director | Strong Market Fit, Attendance Not Confirmed |
| Cedars-Sinai | Academic medical center | Major regional imaging and research center with high relevance to molecular imaging and clinical innovation | cedars-sinai.org | Chair of Radiology, Imaging Operations Director, Procurement Manager, Clinical Research Director | Strong Market Fit, Attendance Not Confirmed |
| Keck Medicine of USC | Academic health system | Relevant for radiology, nuclear medicine, oncology imaging, and academic research adoption | keckmedicine.org | Division Chief, Nuclear Medicine Physician, Imaging IT Director, Strategic Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| City of Hope | Cancer center and research hospital | High relevance to molecular imaging, theranostics, radiopharmaceutical research, and oncology workflows | cityofhope.org | Theranostics Program Director, Imaging Director, Clinical Trials Director, Pharmacy Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Stanford Health Care | Academic health system | Strong fit for advanced imaging, clinical research, and enterprise healthcare procurement | stanfordhealthcare.org | Medical Director Nuclear Medicine, Procurement Director, Informatics Director, Research Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Integrated academic health system | Important buyer-side institution for advanced imaging, radiopharmaceuticals, research collaborations, and clinical protocols | mayoclinic.org | Division Chair, Supply Chain Executive, Imaging Operations Director, Principal Investigator | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Integrated health system | Major imaging and hospital enterprise buyer with research and specialist clinical programs | clevelandclinic.org | Imaging Institute Leader, Supply Chain Director, Radiopharmacy Leader, IT Director | Strong Market Fit, Attendance Not Confirmed |
| Memorial Sloan Kettering Cancer Center | Cancer center | Highly relevant for oncology imaging, theranostics, clinical research, and nuclear medicine applications | mskcc.org | Chief of Nuclear Medicine, Clinical Research Director, Sourcing Manager, Radiation Safety Officer | Strong Market Fit, Attendance Not Confirmed |
| MD Anderson Cancer Center | Cancer center and research institution | Relevant for molecular imaging, radionuclide therapies, and research partnerships | mdanderson.org | Theranostics Lead, Imaging Chair, Clinical Operations Director, Strategic Sourcing Director | Strong Market Fit, Attendance Not Confirmed |
| Veterans Health Administration | Government healthcare system | Relevant public-sector healthcare buyer for imaging, safety, equipment, and enterprise clinical systems | va.gov | Contracting Officer, Imaging Service Chief, Biomedical Engineering Director, Pharmacy Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Medical Director, Nuclear Medicine | Clinical | Director / Executive | Core clinical decision-maker for adoption, protocols, and technology preference |
| 2 | Chair of Radiology / Imaging | Radiology | Executive | Influences capital planning, clinical direction, and department strategy |
| 3 | Director of Imaging Services | Operations | Director | Controls throughput, equipment utilization, vendor service expectations, and workflow purchases |
| 4 | Procurement Director | Procurement / Supply Chain | Director | Owns sourcing process, pricing negotiations, and vendor approval |
| 5 | Strategic Sourcing Manager | Supply Chain | Manager | Relevant for consumables, service contracts, software, and equipment sourcing cycles |
| 6 | Pharmacy Director / Radiopharmacy Manager | Pharmacy | Director / Manager | Key for radiopharmaceutical supply, compliance, storage, and handling decisions |
| 7 | Clinical Research Director / Principal Investigator | Research | Director / Senior | Drives studies, evidence creation, and innovation partnerships |
| 8 | Medical Physicist / Radiation Safety Officer | Safety / Technical | Senior / Manager | Important technical evaluator for safety, QA, and regulatory alignment |
| 9 | IT Director, Imaging Informatics | IT / Informatics | Director | Relevant for PACS, interoperability, cloud, security, and AI deployment |
| 10 | Program Manager, Theranostics / Imaging Service Line | Operations / Program Management | Manager / Director | Coordinates implementation, cross-functional adoption, and vendor engagement |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core buyer universe for imaging equipment, software, radiopharmaceuticals, and service contracts | Hospital imaging departments, enterprise procurement, clinical operations |
| 2 | Medical Devices | Direct relevance for imaging hardware, accessories, monitoring, shielding, and diagnostics tools | Partnerships, channel development, and institutional adoption |
| 3 | Pharmaceuticals | Radiopharmaceutical and molecular diagnostics stakeholders align strongly with the event | Drug development, commercialization, medical affairs, supply coordination |
| 4 | Biotechnology | Biotech firms developing diagnostics, tracers, or precision medicine solutions are relevant participants | Research collaboration and innovation scouting |
| 5 | Research | Academic and translational research institutions are central to this scientific meeting | Clinical trials, investigator-led studies, validation projects |
| 6 | Higher Education | Medical schools and universities often operate nuclear medicine and imaging programs | Faculty outreach, research partnerships, training programs |
| 7 | Information Technology & Services | Imaging informatics, enterprise integration, cloud workflow, and data management are relevant layers | PACS, RIS, interoperability, analytics, support services |
| 8 | Computer Software | Relevant for imaging workflow, AI support, reading tools, reporting, and scheduling | Clinical workflow improvement and data-enabled diagnostics |
| 9 | Government Administration | Public hospital systems and federal healthcare entities may be relevant in procurement and care delivery | Public-sector healthcare acquisition and program management |
| 10 | Import & Export | Useful for specialized international distributors and supply-chain partners in medical technology | Channel partnerships and cross-border product distribution |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer | Not Confirmed | Organizer count not available in the information reviewed | Historical positioning suggests a large specialty meeting with thousands of attendees |
| Exhibitor count | Not publicly confirmed | Not Confirmed | Current exhibitor total not verified | Would require official floor plan, sponsor listing, or exhibitor directory |
| Buyer count | Not publicly confirmed | Not Confirmed | No official buyer segmentation count reviewed | Buyer influence is high, but attendee composition is clinically led rather than procurement-only |
| Speaker count | Not publicly confirmed | Not Confirmed | Agenda volume likely extensive, but count not verified | Scientific annual meetings typically feature a large faculty and abstract program |
| Sponsor count | Not publicly confirmed | Not Confirmed | No verified current-year sponsor total reviewed | Likely meaningful given the medical technology and radiopharma ecosystem |
| Historical attendance positioning | Thousands of specialist attendees | Historical / prior-year evidence | Event reputation and annual flagship status | Useful directional guidance only; not a confirmed 2026 attendance figure |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Molecular imaging | Improved diagnostic precision and clinical workflow | Clinical demos, evidence-based discussions, pilot deployments | Imaging systems, analysis software, workflow optimization tools |
| Radiopharmaceuticals | Reliable supply, storage, safety, therapeutic expansion | Partnership meetings with pharmacy, clinical, and supply chain teams | Drug supply, handling systems, compliance support, cold-chain or protected logistics |
| PET / SPECT imaging | Modality performance, utilization, integration, upgrade planning | Capital equipment conversations, service and maintenance discussions | Scanners, accessories, maintenance, quality control systems |
| Clinical research | Study support, translational science, trial imaging consistency | Research partnerships and investigator engagement | Trial services, analytics, research software, imaging core support |
| Healthcare technology | Interoperability, automation, reporting, workflow visibility | Operational ROI discussions with IT and departmental leaders | PACS, RIS, AI, scheduling, analytics, enterprise integration tools |
| Safety and compliance | Radiation protection, QA, documentation, regulatory readiness | Technical and compliance-led buyer conversations | Radiation safety products, monitoring, shielding, training, audit support |
| Theranostics and precision medicine | Program development, treatment pathways, multidisciplinary coordination | Service-line growth discussions with oncology and imaging leaders | Program consulting, therapeutic supply, training, technology platforms |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Attendees are specialized clinical, operational, research, and supply-side decision influencers in nuclear medicine and imaging. |
| Decision-maker availability | High | Department heads, physician leaders, and enterprise stakeholders are likely present, though many decisions are committee-driven. |
| Data collection potential | Medium | Good for exhibitor outreach and post-event prospecting, but current-year attendee transparency may be limited. |
| Apollo targeting potential | Very High | The audience maps well to hospital systems, academic medicine, radiology, research, pharma, biotech, and imaging IT roles. |
| Geographic targeting potential | High | Good combination of Los Angeles local targets, California regional accounts, and national specialist accounts. |
| Best outreach approach | High | Use clinically credible messaging, evidence-led value propositions, and account-based outreach to imaging, radiopharmacy, and procurement stakeholders. |
| Overall lead quality | High | Best suited for high-value B2B healthcare sales, strategic partnerships, and specialist account penetration. |
| Best use case | High | Ideal for exhibitor targeting, account mapping, ABM campaigns, partnership outreach, and specialist healthcare buyer profiling. |
| Limitations / risks | Medium | Clinical influence does not always equal direct budget authority, and publicly accessible attendee lists may be limited. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Information Technology & Services; Computer Software; Government Administration | Build a precise healthcare, imaging, and research buyer universe |
| Departments | Operations; Purchasing; Information Technology; Research; Health Care Services; Program Management | Capture both direct purchasers and clinical/technical influencers |
| Seniority | C-Level; VP; Director; Head; Manager; Partner where applicable | Focus on budget authority and implementation leadership |
| Job titles | Medical Director Nuclear Medicine; Director of Imaging; Chair of Radiology; Procurement Director; Strategic Sourcing Manager; Radiopharmacy Manager; Pharmacy Director; Imaging Informatics Director; Clinical Research Director; Radiation Safety Officer | Prioritize titles aligned to adoption, sourcing, and workflow needs |
| Geography | United States; California; Los Angeles metro; major academic medical hubs | Start local and regional, then expand to national accounts |
| Employee size | 201-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,001+ | Focus on hospitals, health systems, academic centers, and larger solution providers |
| Keywords | nuclear medicine, molecular imaging, PET, SPECT, theranostics, radiopharmacy, radiopharmaceutical, imaging services, radiology informatics, diagnostic imaging | Surface specialist organizations and role holders tied to the event theme |
| Technologies | PACS, RIS, cloud imaging, healthcare analytics, interoperability platforms where relevant | Helpful for healthcare IT, workflow, and informatics solution targeting |
| Revenue range | Mid-market to enterprise healthcare organizations | Concentrates effort on accounts with purchasing capacity and multi-site impact |
| Company type | Hospitals, health systems, academic medical centers, research institutions, cancer centers, public healthcare systems | Align outreach to buyer-side organizations rather than general vendor lists |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Society of Nuclear Medicine and Molecular Imaging (SNMMI) | Official organizer website | Organizer identity, society scope, event ownership context | High |
| Los Angeles Convention Center | Official venue website | Venue identity and host location context | High |
| User-supplied event details | Provided event inputs | Event title, city, state, country, venue, and event dates | Medium to High |
| Official current-year attendee, exhibitor, sponsor, and attendance totals | Verification note | Not confirmed in the information reviewed for this data sheet | Pending direct event-page confirmation |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to SNMMI 2026 Annual Meeting — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.